Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The role for estrogen receptor-alpha and prolactin receptor in sex-dependent DEN-induced liver tumorigenesis.

Bigsby RM, Caperell-Grant A.

Carcinogenesis. 2011 Aug;32(8):1162-6. doi: 10.1093/carcin/bgr094. Epub 2011 May 23.

2.
3.

Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.

Arendt LM, Grafwallner-Huseth TL, Schuler LA.

Am J Pathol. 2009 Mar;174(3):1065-74. doi: 10.2353/ajpath.2009.080719. Epub 2009 Jan 29.

4.

Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous.

Kemp CJ, Leary CN, Drinkwater NR.

Proc Natl Acad Sci U S A. 1989 Oct;86(19):7505-9.

5.

Characterization of multiple first exons in murine prolactin receptor gene and the effect of prolactin on their expression in the choroid plexus.

Tabata H, Kobayashi M, Ikeda JH, Nakao N, Saito TR, Tanaka M.

J Mol Endocrinol. 2012 Feb 29;48(2):169-76. doi: 10.1530/JME-11-0122. Print 2012 Apr.

PMID:
22294444
6.

Role of the pituitary in tumor promotion with ethinyl estradiol in rat liver.

Hallstrom IP, Liao DZ, Assefaw-Redda Y, Ohlson LC, Sahlin L, Eneroth P, Eriksson LC, Gustafsson JA, Blanck A.

Hepatology. 1996 Oct;24(4):849-54.

PMID:
8855187
7.

Steroid feedback on gonadotropin release and pituitary gonadotropin subunit mRNA in mice lacking a functional estrogen receptor alpha.

Wersinger SR, Haisenleder DJ, Lubahn DB, Rissman EF.

Endocrine. 1999 Oct;11(2):137-43.

PMID:
10709760
8.

Estrogen receptor alpha-induced cholecystokinin type A receptor expression in the female mouse pituitary.

Kim HJ, Gieske MC, Hudgins S, Kim BG, Krust A, Chambon P, Ko C.

J Endocrinol. 2007 Dec;195(3):393-405.

9.
10.

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M.

Science. 2007 Jul 6;317(5834):121-4. Erratum in: Science. 2009 Dec 4;326(5958):1346.

11.

Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.

Arendt LM, Rugowski DE, Grafwallner-Huseth TA, Garcia-Barchino MJ, Rui H, Schuler LA.

Breast Cancer Res. 2011 Jan 28;13(1):R11. doi: 10.1186/bcr2819.

13.

Estrogen receptor-alpha (ERalpha), but not ERbeta, modulates estrogen stimulation of the ERalpha-truncated variant, TERP-1.

Schreihofer DA, Rowe DF, Rissman EF, Scordalakes EM, Gustafsson J JÅ, Shupnik MA.

Endocrinology. 2002 Nov;143(11):4196-202.

PMID:
12399412
14.
15.

Strain dependent effects of sex hormones on hepatocarcinogenesis in mice.

Poole TM, Drinkwater NR.

Carcinogenesis. 1996 Feb;17(2):191-6.

PMID:
8625437
16.
17.

The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.

Fiorillo AA, Medler TR, Feeney YB, Wetz SM, Tommerdahl KL, Clevenger CV.

Am J Pathol. 2013 Jan;182(1):217-33. doi: 10.1016/j.ajpath.2012.09.021. Epub 2012 Nov 14.

PMID:
23159947
18.

Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.

Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA.

Endocr Rev. 1998 Jun;19(3):225-68. Review.

PMID:
9626554
19.

A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice.

Sims NA, Clément-Lacroix P, Minet D, Fraslon-Vanhulle C, Gaillard-Kelly M, Resche-Rigon M, Baron R.

J Clin Invest. 2003 May;111(9):1319-27.

Supplemental Content

Support Center